Merck signposts a new strategy for patent owners in India

US pharmaceutical company Merck & Co – known as Merck Sharp & Dohme (MSD) outside of North America – has entered into an alliance with generic drug maker Cipla to co-market one of its antiretroviral treatments in India, Bloomberg reports. The…

Get unlimited access to all IAM content